FOLD - AMICUS THERAPEUTICS, INC.

QQQ $ 435.98 $ 3.66 (0.85 %)

DIA $ 386.87 $ 0.13 (0.03 %)

SPY $ 511.25 $ 6.22 (1.23 %)

TLT $ 89.88 $ -0.23 (-0.26 %)

GLD $ 212.97 $ -0.45 (-0.21 %)

Previous Close

$ 10.4

Open

$ 10.76

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 10.36 - $ 10.77

52 Week Range

$ 9.70 - $ 14.57

Volume

2,576,847

Average Volume

Market Cap

3.08B

Beta (5Y Monthly)

$ 0.94

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-07-2022	09-30-2022	10-Q
7	08-04-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	02-24-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	03-01-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	02-28-2019	12-31-2018	10-K
22	11-05-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-01-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-07-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	03-01-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	05-03-2016	03-31-2016	10-Q
33	02-29-2016	12-31-2015	10-K
34	11-04-2015	09-30-2015	10-Q
35	08-05-2015	06-30-2015	10-Q
36	05-05-2015	03-31-2015	10-Q
37	03-03-2015	12-31-2014	10-K
38	11-06-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-05-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Overweight on Amicus T...
03/18/2024 11:49:20

JP Morgan analyst Anupam Rama maintains Amicus Therapeutics (NASDAQ:FOLD) with a Overweight and lowers the price target from...

Cantor Fitzgerald Reiterates Overweight on...
02/29/2024 18:47:39

Cantor Fitzgerald analyst Kristen Kluska reiterates Amicus Therapeutics (NASDAQ:FOLD) with a Overweight and maintains $22 pr...

Amicus Therapeutics Projects 2024 Galafold...
02/28/2024 12:07:55

Amicus Therapeutics Q4 Adj EPS $0.01 Beats...
02/28/2024 12:06:30

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly Adj earnings of $0.01 per share which beat the analyst consensus estimate ...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Amicus Therapeutics Says It Received 2024 ...
02/08/2024 12:14:50

Amicus Therapeutics Reports Preliminary 20...
01/07/2024 22:38:59

Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc., stated, "Last year was an incredible ...

The Analyst Landscape: 4 Takes On Amicus T...
12/19/2023 15:01:46

Morgan Stanley Upgrades Amicus Therapeutic...
12/19/2023 14:09:16

Morgan Stanley analyst Jeffrey Hung upgrades Amicus Therapeutics (NASDAQ:FOLD) from Equal-Weight to Overweight and raises th...

Amicus Therapeutics' John Crowley, Executi...
12/05/2023 11:05:02

Morgan Stanley Maintains Equal-Weight on A...
11/09/2023 13:54:54

Morgan Stanley analyst Andrew Galler maintains Amicus Therapeutics (NASDAQ:FOLD) with a Equal-Weight and raises the price ta...

Amicus Therapeutics Is On-Track To Achieve...
11/08/2023 12:13:14

For FY23, Amicus Therapeutics Is Increasin...
11/08/2023 12:11:59

Amicus Therapeutics Q3 EPS $(0.07) Beats $...
11/08/2023 12:10:12

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $...

Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Morgan Stanley Maintains Equal-Weight on A...
10/10/2023 15:17:49

Morgan Stanley analyst Andrew Galler maintains Amicus Therapeutics (NASDAQ:FOLD) with a Equal-Weight and lowers the price ta...

Amicus Therapeutics And Blackstone Enter I...
10/02/2023 12:22:26

Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule Blackstone to also Purchase $30M of Amicus C...

JP Morgan Maintains Overweight on Amicus T...
09/29/2023 11:25:16

JP Morgan analyst Anupam Rama maintains Amicus Therapeutics (NASDAQ:FOLD) with a Overweight and raises the price target from...

nike-opko-health-and-other-big-stocks-moving-higher-in-fridays-pre-market-session

Nike, OPKO Health And Other Big Stocks Mov...
09/29/2023 09:59:47

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading...

amicus-therapeutics-drug-scores-fda-approval-for-rare-inherited-pompe-disease

Amicus Therapeutics Drug Scores FDA Approv...
09/28/2023 16:41:40

The FDA has approved Amicus Therapeutics' (NASDAQ: FOLD) Pombiliti (cipaglucosidase alfa-atga)+Opfolda (miglustat) 65mg cap...